Oncology Virtual Partnering Forum
Date and Time
Thursday Oct 20, 2022
12:00 PM - 2:00 PM EDT
Location
Virtual
Fees/Admission
$99 AUTM Members / $199 Non-Members
Website
Contact Information
Galo Mejia, Technology Marketing Associate, Duke University
Send Email
Description
From the Cancer Moonshot to the Grand Cancer Challenge, there’s palpable urgency to advance cutting edge technologies out of academic labs that can treat and prevent cancer.
Are you looking for a company partner to advance a new oncology target, compound, or biomarker? At AUTM’s Oncology Partnering Forum, leading oncology companies share valuable intel on their:
-
Oncology discovery pipeline
-
Current scouting priorities in oncology for collaboration or licensing with academic partners
-
Preferred format, content and process for vetting academic technologies
Meet company reps from Astellas Pharma, ElevateBio, AbbVie, Johnson & Johnson Innovations, and Qualigen Therapeutics. The Partnering Forum will open with a presentation about the Cancer Grand Challenge by program managers from the National Cancer Institute and Cancer Research UK. Learn more about this trans-Atlantic collaborative funding opportunity, and its unique intellectual property ownership and licensing structures. The forum also includes a panel discussion on “Partnering in the Crowded Immuno-Oncology Landscape” with key opinion leaders from venture, industry and philanthropy.
